Ba
Non vérifié

Bavarian Nordic A/S

Ce que nous écrivons

BiotechnologieFinanceManagement/Organisation d'EntreprisePolitique ÉtrangèrePublicité/Marketing/Médias/Communication
12/05/2026
Biotechnologie
Management/Organisation d'Entreprise
Politique Étrangère
Bavarian Nordic Announces Interim Results for the First Three Months of 2026
1.00
11/05/2026
Biotechnologie
Management/Organisation d'Entreprise
Politique Étrangère
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines
1.00
15/04/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine
1.00
27/03/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years
1.00
11/03/2026
Biotechnologie
Finance
Politique Étrangère
Bavarian Nordic Publishes Annual Report 2025
1.00
11/03/2026
Biotechnologie
Management/Organisation d'Entreprise
Médecine Santé Bien-être
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
1.00
01/03/2026
Biotechnologie
Politique Étrangère
Paul Chaplin Steps Down as CEO of Bavarian Nordic
1.00
17/02/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0